Library / Laws / 115th Congress / House Bills / H.R. 2026
H.R. 2026
To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-04-06 | 2.3K | ⠃⠗⠋ |